NPI: 1366874877 · JEROME, ID 83338 · Critical Access Hospital · NPI assigned 08/07/2013
Authorized official FOWLER, KATHRYN controls 18+ related entities in our dataset. Read more
| Authorized Official | FOWLER, KATHRYN (SENIOR VP, CFO) |
| Parent Organization | ST LUKES HEALTH SYSTEM LTD |
| NPI Enumeration Date | 08/07/2013 |
Other providers sharing the same authorized official: FOWLER, KATHRYN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 7,739 | $170K |
| 2019 | 9,858 | $288K |
| 2020 | 5,142 | $112K |
| 2021 | 51 | $24.03 |
| 2022 | 659 | $2K |
| 2023 | 656 | $4K |
| 2024 | 232 | $967.19 |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 41899 | Unlisted procedure, dentoalveolar structures | 169 | 165 | $394K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3,796 | 3,399 | $24K |
| 80053 | Comprehensive metabolic panel | 2,874 | 2,640 | $24K |
| 84443 | Thyroid stimulating hormone (TSH) | 955 | 930 | $13K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 508 | 496 | $10K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 117 | 112 | $10K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 233 | 225 | $8K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 233 | 225 | $8K |
| 71046 | Radiologic examination, chest; 2 views | 660 | 636 | $8K |
| 36415 | Collection of venous blood by venipuncture | 3,944 | 3,455 | $7K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 751 | 723 | $5K |
| 87430 | 358 | 353 | $5K | |
| 83690 | 735 | 680 | $5K | |
| 81001 | 1,428 | 1,355 | $5K | |
| 87081 | 627 | 617 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 567 | 510 | $4K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 28 | 26 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | 658 | 649 | $4K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 433 | 361 | $4K |
| 80061 | Lipid panel | 361 | 355 | $3K |
| 86140 | 557 | 518 | $3K | |
| 87077 | 320 | 313 | $3K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 711 | 632 | $2K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 25 | 25 | $2K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 17 | 12 | $2K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 494 | 429 | $2K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 12 | 12 | $2K |
| 83605 | 159 | 139 | $1K | |
| J7050 | Infusion, normal saline solution, 250 cc | 405 | 340 | $1K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 14 | 12 | $1K |
| 84484 | 108 | 92 | $1K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 25 | 25 | $999.14 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 544 | 481 | $863.41 |
| 87420 | 39 | 39 | $533.39 | |
| 81025 | 68 | 67 | $481.05 | |
| 71045 | Radiologic examination, chest; single view | 64 | 58 | $395.29 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 516 | 448 | $377.09 |
| 80306 | 27 | 27 | $367.25 | |
| 87186 | 39 | 37 | $301.11 | |
| 73110 | 13 | 13 | $259.95 | |
| 73610 | 13 | 12 | $221.76 | |
| 86703 | 13 | 12 | $143.79 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 135 | 131 | $127.92 |
| 82962 | 38 | 26 | $118.46 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 47 | 40 | $95.72 |
| J2704 | Injection, propofol, 10 mg | 66 | 66 | $72.73 |
| 86901 | 12 | 12 | $40.59 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 85 | 82 | $36.68 |
| 82570 | 14 | 13 | $27.68 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 290 | 255 | $20.43 |
| 80050 | General health panel | 32 | 32 | $0.00 |